The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity

BACKGROUND: Cannabinoid type-1 (CB1) receptor inverse agonists improve type 2 diabetes and dyslipidaemia but were discontinued due to adverse psychiatric effects. Δ(9)-Tetrahydrocannabivarin (THCV) is a neutral CB1 antagonist producing hypophagia and body weight reduction in lean mice. We investigat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Wargent, E T, Zaibi, M S, Silvestri, C, Hislop, D C, Stocker, C J, Stott, C G, Guy, G W, Duncan, M, Di Marzo, V, Cawthorne, M A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2013
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671751/
https://ncbi.nlm.nih.gov/pubmed/23712280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nutd.2013.9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak